by Ket Patel | May 13, 2019 | Arrhythmia, Atrial Fibrillation
The results from the full cohort analysis of the REVERSE-AD study provide compelling evidence for idarucizumab’s ability to immediately, completely and sustainably reverse the anticoagulant effect of dabigatran. This video summarizes the key results of the RE-VERSE AD...
by Ket Patel | May 13, 2019 | Interventional Cardiology
Animated infographic Video summarizing the RE-DUAL PCI Results published in NEJM comprehensively in two...
by Ket Patel | May 10, 2019 | Home video, Interventional Cardiology
Expert interview with Dr. Jur ten Berg about dual antithrombotic therapy with Dabigatran in AF patients post PCI. In the interview he focuses mainly on new subanalyses, presented at ACC Does the Discontinuation of ASA in the Warfarin-TT Arm Influence the Treatment...
by Ket Patel | May 9, 2019 | Home video, Interventional Cardiology
Interview series with Professor Stefan Hohnloser about dual antithrombotic therapy with Dabigatran in AF patients post PCI Should dabigatran dual therapy be the default strategy for most patients with AF and ACS? Which dabigatran dose would be recommended for patients...
by Ket Patel | May 9, 2019 | Atrial Fibrillation, Home video, Interventional Cardiology
Dr. Dominick Angiolillo summarizes the results of the RE-DUAL PCI study showing the safety of dabigatran dual therapy post-PCI with doses approved for stroke prevention in AF. He also shows data on subgroup analysis in patients with ACS / no ACS as an index event and...
